Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Preliminary Market Consultation, Pursuant To Art. 77 Of Legislative Decree 36/2023, For The Verification Of Non-Fungibility For The Supply Of A System For The Quantitative Determination Of Biological Drugs (Infliximab And Adalimumab) And Related Anti-Drug Antibodies Using A Rapid Immunometric Capture Elisa System, Required By The U.O.S. Biochemistry Pharmacology And Neonatal Screening, Pursuant To Art. 76 Of Legislative Decree 36/2023.

Istituto Giannina Gaslini Italy has Released a tender for Preliminary Market Consultation, Pursuant To Art. 77 Of Legislative Decree 36/2023, For The Verification Of Non-Fungibility For The Supply Of A System For The Quantitative Determination Of Biological Drugs (Infliximab And Adalimumab) And Related Anti-Drug Antibodies Using A Rapid Immunometric Capture Elisa System, Required By The U.O.S. Biochemistry Pharmacology And Neonatal Screening, Pursuant To Art. 76 Of Legislative Decree 36/2023. in laboratory equipment and services . The tender was released on Oct 24, 2025.

Country - Italy

Summary - Preliminary Market Consultation, Pursuant To Art. 77 Of Legislative Decree 36/2023, For The Verification Of Non-Fungibility For The Supply Of A System For The Quantitative Determination Of Biological Drugs (Infliximab And Adalimumab) And Related Anti-Drug Antibodies Using A Rapid Immunometric Capture Elisa System, Required By The U.O.S. Biochemistry Pharmacology And Neonatal Screening, Pursuant To Art. 76 Of Legislative Decree 36/2023.

Deadline - Nov 07, 2025

GT reference number - 120895824

Product classification - Biochemical analysers

Organization Details:

  Address - Italy

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 120895824

  Document Type - Tender Notices

Notice Details and Documents:

Description - notice_title: Preliminary Market Consultation, Pursuant To Art. 77 Of Legislative Decree 36/2023, For The Verification Of Non-Fungibility For The Supply Of A System For The Quantitative Determination Of Biological Drugs (Infliximab And Adalimumab) An d Related Anti-Drug Antibodies Using A Rapid Immunometric Capture Elisa System, Required By The U.O.S. Biochemistry Pharmacology And Neonatal Screening, Pursuant To Art. 76 Of Legislative Decree 36/2023.local title:: Consultazione preliminare di Mercato, ai sensi dell’art. 77 del D.Lgs 36/2023, per la verifica di infungibilità per la fornitura di un Sistema per la determinazione quantitativa di farmaci biologici (infliximab e adalimumab) e rel

Gt Ref Id - 120895824

Deadline - Nov 07, 2025

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database